ORIGINAL ARTICLE. Intraductal Papillary-Mucinous Tumors of the Pancreas
|
|
- Lee Bryan
- 6 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Intraductal Papillary-Mucinous Tumors of the Pancreas Predictive Criteria of Malignancy According to Pathological Examination of 53 Cases Pierre Bernard, MD; Jean-Yves Scoazec, MD, PhD; Madeleine Joubert, MD; Xavier Kahn, MD; Joël Le Borgne, MD; Françoise Berger, MD, PhD; Christian Partensky, MD Background: One of the main problems in the management and treatment of intraductal papillary-mucinous tumors is the lack of a reliable predictive factor for malignancy. Hypothesis: Surgical treatment could be adapted to macroscopic criteria (presence of mural nodules and diameter of the pancreatic duct and of the lesion) or to tumor location (main duct, branch duct, or combined lesions) associated with benign or malignant forms. Design: Retrospective study. Setting: Two university and tertiary referral centers. Patients: Fifty-three consecutive patients who underwent pancreatic resection for intraductal papillarymucinous tumors between January 1, 1985, and December 31, Results: Macroscopic analyses of tumors showed 6 main duct lesions, 12 branch duct lesions, and 35 combined lesions. A carcinoma was present in 33 cases (62%): 22 (41%) were invasive and 11 (21%) were noninvasive; 9 (17%) were borderline tumors and 11 (21%) were benign. Carcinoma and invasive carcinoma forms were less frequent in branch duct lesions (P.001 and P=.009, respectively). Mural nodules were more frequent in carcinomas (P=.006) and invasive carcinomas (P.001), with a positive predictive value of malignancy of 81%. The diameter of lesions (branch duct lesion 30 mm) or main duct (main pancreatic duct 15 mm in combined or main pancreatic duct lesions) did not correlate with malignancy. Conclusions: No carcinoma occurred in branch duct types smaller than 30 mm without mural nodules. Limited resection may be appropriate only in this type of tumor. Arch Surg. 2002;137: From the Departments of Surgery (Drs Bernard and Partensky) and Pathology (Drs Scoazec and Berger), Hospital E. Herriot, Lyon, France; and the Departments of Pathology (Dr Joubert) and Surgery (Drs Kahn and Le Borgne), Hôtel-Dieu, Nantes, France. INTRADUCTAL PAPILLARY-mucinous tumors of the pancreas (IPMTs), recently defined by the World Health Organization (WHO), 1 are characterized by the dilation of the main and/or branch pancreatic ducts and, occasionally, by the presence of mural nodules (papillary excrescences or protuberances) within the dilated pancreatic ducts. The IPMTs are frequently classified into 3 subtypes on the basis of the site of tumor involvement: main duct type, branch duct type, and combined type with both main and branch duct lesions. 2 These intraductal lesions with a malignant potential are graded according to the WHO classification as adenoma, borderline, carcinoma in situ, and invasive carcinoma. 1 Appropriate management of IPMTs requires the differentiation between premalignant and malignant lesions, 2 but preoperative assessment fails to predict neoplasm extension in up to 40% of cases. 3 Recent studies 3-6 have demonstrated that poor survival after surgery is highly related to the presence of invasive carcinoma. An analysis of macroscopic features of IPMT in a retrospective study of resected pancreatic specimens may help in the correct prediction of invasive carcinoma. METHODS Fifty-three consecutive patients, including 31 men and 22 women with a median age of 61.2 years (range, years), who underwent a pancreatic resection for IPMT in 2 institutions between January 1, 1985, and December 31, 2000, were included in this study. Operative procedures were the following: total pancreatectomy (n=4), pylorus-preserving pancreatoduodenectomy (n=30), pancreatoduodenectomy with antrectomy (n=6), spleenpreserving distal pancreatectomy (n=7), distal pancreatectomy (n=4), and middle resection of the pancreas (n=2). Pathological examination after section of the pancreatic specimen along the main pancreatic duct and dilated branch ducts enabled 4 criteria to be defined: (1) IPMT subtype according to the classification used by 1274
2 Table 1. Histologic Stage Compared With Morphologic Classification Benign Forms, No. Malignant Forms, No. No. of Cases Main duct type Branch duct type Combined type Table 2. Histologic Stage Compared With Size and Type of Lesion Benign Forms, No. Malignant Forms, No. Size, mm Main duct type or combined type Branch duct type Sugiyama and Atomi 2 ; (2) size of the main pancreatic duct for main and combined duct types; (3) size of cystic dilation in branch duct type; and (4) the presence of mural nodules. The correlations between these criteria and the epithelial intraductal lesions were studied. Intraductal lesions were classified into 4 grades, according to the WHO classification, and the most severe grade of epithelial dysplasia was taken into account. According to previous assessment of imaging findings indicative of carcinoma, 2 we retained as threshold values a main pancreatic duct diameter of 15 mm or more for the main and combined pancreatic duct types, a cystic lesion diameter of 30 mm or more for branch duct types, and obvious mural nodules equal to or greater than 3 mm 7 for all of the types. A second pathological examination took into account all of the resected specimen. Differences between categorical variables were evaluated by 2 test or Fisher exact test. Differences were considered significant at P.05. RESULTS The IPMTs were classified as invasive carcinoma in 22 cases (41%), noninvasive carcinoma (carcinoma in situ or severe dysplasia) in 11 cases (21%), borderline (moderate dysplasia) in 9 cases (17%), and adenoma (mild dysplasia) in 11 cases (21%). A malignant form was found in 73% of cases (24/33) in patients aged 60 years or older and in 45% (9/20) of the remaining patients (P=.04). There were 6 cases of main duct type (11%), 12 cases of branch duct type (23%), and 35 cases of combined duct type(66%). Thenumbersofmalignantorinvasiveformswere similar according to right or left location of the tumor. In fact,amalignantformwasnotedin61%(22/36)ofcaseswith a right location and in 55% (6/11) in cases with a left location. Furthermore, an invasive form was found in 44% (16/ 36) with right location and in 27% (3/11) with left location (middle and total pancreatectomies were excluded). The correlations between the histologic grade and the classification used by Sugiyama and Atomi 2 are shown in Table 1. The rate of malignant tumors was significantly higher in the main duct type (83%; P=.02) and in the combined type (74%; P=.002) compared with the branch duct type (17%). Among the malignant forms, the rate of invasive carcinomas was significantly higher in the main duct type (83%; P=.004) and in the combined duct type (46%; P=.04) compared with the branch duct type (8%). The rate of carcinoma ranged from 17% to 76% according to the absence or presence of main pancreatic duct lesions (P.001), and the rate of invasive carcinoma ranged from 8% to 51% according to the absence or presence of main pancreatic duct lesions (P=.009). A benign form (adenoma and borderline) was more frequent in the branch duct type (83%) than in the main duct type (17%; P=.02) or the combined type (26%; P=.002). A diameter of the main pancreatic duct equal to or greater than 15 mm was observed in 16 cases of main duct and combined types (n=41) and was not significantly associated with a carcinoma (Table 2). When the diameter was equal to or greater than 15 mm, the tumors were malignant in 88% (14/16) and invasive in 50% (8/16) of cases, but when the diameter was less than 15 mm, the tumors were malignant in 68% (17/25) and invasive in 52% (13/25). We noted 3 noninvasive carcinomas and 2 invasive carcinomas with a diameter of the main pancreatic duct less than 15 mm without any mural nodules (Table 3). Comparison between the histologic grade and the size of the cystic dilation in the branch duct type did not disclose any correlation. Nevertheless, a carcinoma was discovered in only 2 cases with a cystic dilation less than 30 mm and was associated with mural nodules (Table 3). All 7 patients with a dilation less than 30 mm and without mural nodules were still alive with no evidence of disease after a mean±sd of 3.4±1.4 years of follow-up. Mural nodules were found in 26 cases (49%; Table 3) and were more frequent (P=.006) in malignant forms (64% [21/33]) than benign forms (25% [5/20]). An in- 1275
3 Table 3. Presence and Proportion of Mural Nodules According to Histologic Stage, Size, and Type of Lesion No. of Tumors With Nodules/No. of Cases (%) Benign Forms Malignant Forms Size, mm Main duct type or combined type 15 0/1 1/1 (100) 2/6 (33) 5/8 (62) 15 3/5 (60) 1/3 (33) 1/4 (25) 11/13 (85) Branch duct type 30 0/1 0/2 0/0 0/0 30 0/4 0/3 1/1 (100) 1/1 (100) Table 4. Histologic Stage According to the Presence of Mural Nodules vasive carcinoma was more often associated (P.001) with mural nodules (77% [17/22]) than the benign forms (25% [5/20]) or all the other cases (29% [9/31]). The discovery of mural nodules was a predictive factor for malignancy, with a sensitivity of 64%, a specificity of 75%, a positive predictive value of 81%, and a negative predictive value of 56% (Table 4). COMMENT No. (%) Malignant Forms Benign Forms Total Mural nodules 21 (64) 5 (25) 26 (49) No mural nodules 12 (36) 15 (75) 27 (51) Total 33 (100) 20 (100) 53 (100) Correct prediction of malignancy, especially for invasive adenocarcinomas, remains one of the major problems in the management and optimal treatment of IPMTs. 2 Since survival after surgery is closely related to the presence of invasive carcinoma, 4-10 it is of major importance to point out the predictive criteria of malignancy, particularly of invasive carcinoma. This study confirms the high rate of malignant tumors (62%), including noninvasive (21%) and invasive (41%) carcinomas, according to recent reports. 2,6 In a literature review, the prevalence of malignant tumors reached 72%, 11 but in other reports, the rate of malignancy was less than 50%. 3,10 It is controversial to focus exclusively on the incidence of invasive adenocarcinomas (from 42% to 45%) and to class the remaining patients as having dysplasia. 4,6 According to the WHO classification, patients with severe dysplasia or in situ carcinoma are assigned to the noninvasive carcinoma group. 1 In our study, patient characteristics were similar to those in previous reports concerning mean age and male predominance (sex ratio, 1.4). 2,7,9-15 Like Paye et al 3 and Yamao et al, 10 we noted a correlation between age and malignancy. The IPMTs are classified into 3 subtypes, based on the site of duct involvement by tumor (main duct type, branch duct type, and combined duct type with both main and branch duct involvement). 2 According to this classification, the frequency of different subtypes is variable: 29% to 47% for main duct type, 14% to 29% for combined duct type, and 30% to 57% for branch duct type. 2,11,14,16 In our study, the histologic findings differed, with a higher rate of combined duct type (66%) and a lower rate of main duct type (11%) and branch duct type (23%). The differences in frequency of different subtypes could be explained by a second and careful pathological examination, which showed the frequent association of lesions within both the main and branch ducts and an increase in the number of combined duct types at the expense of the rate of main and branch duct types. These features are in agreement with the recent classification into 2 types according to the presence or absence of lesions of the main pancreatic duct. According to histologic findings, lesions of the main duct type are predominant (60%-78%). 17,18 In our series, lesions of the main pancreatic duct (isolated or associated) were discovered in 77% of cases. It is debatable whether a main duct type can exist without branch duct lesions. The rate of carcinomas is significantly higher in IPMTs with a tumor in the main pancreatic duct, including main and combined duct types (76% in our series), and attains 92% in some reports. 18 The rate of invasive carcinoma ranges from 13% to 56% according to the absence or presence of main pancreatic duct lesions. 2 In our series, the same rate ranges from 8% to 51% (P=.009). Other groups have shown a better histologic form in the case of branch duct lesions 3,11,16 as well as a better prognosis. 18 In Sugiyama and Atomi s study, 2 main pancreatic duct diameter equal to or greater than 15 mm (for main and combined duct types) and size of the cystic tumor equal to or greater than 30 mm (for branch duct type) showed a high prevalence of adenocarcinoma. They chose the threshold value of 15 mm for the main pancreatic duct, because 70% of tumors with a main pancreatic duct diameter of less than 15 mm were benign, whereas 87% of those with a diameter of 15 mm or more were malignant. In the case of branch duct type tumors, 89% of tumors larger than 30 mm were malignant, in contrast to a rate of 29% for tumors smaller than 30 mm, with no case of invasive carcinoma. The findings were different in our series. The risk of malignancy was not significantly different when the main pancreatic duct diameter was equal to or greater than 15 mm (88%) or less than 15 mm (68%). A diameter equal to or greater than 10 mm is probably more reliable in defining the risk of 1276
4 malignancy. 19 For branch duct type, contrary to the findings of the Sugiyama and Atomi study, there was no correlation between the size of cystic duct dilation and malignancy. 2 Tumors with mural nodules have a significantly higher incidence of carcinoma than tumors without nodules, 2,14 in accordance with our results showing more cases of the malignant form (P=.006) and of invasive carcinoma (P.001) in patients with mural nodules. The degree of papilla formation may range from microscopic folds to florid branching papillary nodules (up to several centimeters) with 2 different patterns of papillae, ie, intestinal type (85%) and pancreatobiliary type (15%). 20 Mural nodules 3 mm or larger within the dilated main or branch pancreatic ducts can be detected in 53% to 64% of cases. 2,19 In our series, they were found in 49% of cases. The positive predictive value for the malignant form is 81% of cases with mural nodules, and the latter were associated with a malignant form and invasive carcinoma, in accordance with previous results. 2 We believe that it is more important to associate the criterion of size with the presence of mural nodules. Indeed, in Sugiyama and Atomi s series, the 2 patients with a carcinoma and a diameter of the tumor less than 30 mm had mural nodules. 2 In accordance with these authors, we did not find any carcinoma in branch duct types when the lesion diameter was less than 30 mm if patients did not have mural nodules. In our branch duct type group, 2 patients had carcinoma and lesions smaller than 30 mm, but they had mural nodules. However, the results are different with the diameter of the main pancreatic duct in patients with main duct type and combined pancreatic duct type. We had 3 noninvasive carcinomas and 2 invasive carcinomas without mural nodules when the main pancreatic duct was less than 15 mm. As a result, the presence of mural nodules plays a crucial role in determining surgical strategy, especially in small branch duct tumors. This problem illustrates the significance of radiologic examinations for surgical strategy. Endoscopic ultrasonography and magnetic resonance cholangiopancreatography (MRCP) were better than endoscopic retrograde cholangiopancreatography (ERCP) for observing the location of the tumor and the presence of mural nodules. 2,9 Nevertheless, ERCP could help to predict malignancy with analysis of bile juice, as in the Tateishi et al 21 series. In that study, the K-ras mutation was found in 9 of 15 patients with IPMT vs 1 of 27 patients without carcinoma 21 ; however, this type of analysis remains controversial. 3 Both MRCP and endoscopic ultrasonography can find signs of invasion in the case of invasive carcinoma but are not able to distinguish between intraductal carcinomas and benign lesions. 2 Sugiyama and Atomi 2 reserved ERCP for examining patients with equivocal MRCP findings, because MRCP is less operator-dependent and less invasive than ERCP. Recently, intraductal ultrasonography with a 2.5-mm-diameter miniature ultrasonographic probe was used to locate the tumor and the mural nodules and to perform biopsies, 22 but this method of performing biopsies is exposed to inaccuracies because of varying degrees of epithelial dysplasia in different parts of the ductal system. 3 Surgical treatment is mandatory because of the frequency of malignant forms 9,13,15,23-25 and because of the subsequent mortality due to invasive carcinoma. 9,10 Frozen section of the pancreatic margin is one of the guidelines of the adequacy of the pancreatic resection. 3,24,26,27 Cuillerier et al 9 use it in cases of noninvasive carcinoma to extend pancreatic resection until disease-free margins are obtained. Operative ultrasonography can help to show local invasion, mural nodules, and lymph node involvement. 14 The diagnosis sensitivity seems to be better with a high-resolution annular array transducer than with conventional operative ultrasonography. 7 Multiple locations are possible, 7,9,10,25 and Kobari et al 18 suggested performing a total pancreatectomy routinely in the main duct type. In contrast, Cuillerier et al 9 consider that total pancreatectomy should be performed only in highly selected patients, according to the general condition and age, even in the case of invasive carcinoma. Most authors choose to perform operations that preserve as much pancreatic tissue as possible when surgery is performed at an early stage of the disease. 10,14,18,26,28 These operations include pylorus-preserving head pancreatectomy, duodenum-preserving pancreatic head resections with direct anastomosis between the remnant pancreas and the duodenum, 17,23,29 pancreatic head resection with segmental duodenectomy, 30 inferior head resection of the pancreas, 31 segmental resection for tumors localized in the body, 10,32 or enucleoresection. 33 In this last type of resection, the patients must have routine examination during the postoperative follow-up mainly by MRCP, which can be associated with endoscopic ultrasonography. Indeed, in the series by the French Association of Surgery, 1 of the 2 patients who underwent enucleoresection presented with a recurrence that required a distal pancreatectomy 2 years after the initial surgery. 12 Takeyoshi et al 34 performed middle pancreatectomy and local lymph node resection in one patient with body lesions of less than 30 mm at intraoperative ultrasonography and with negative frozen section of the pancreatic margin, although the final diagnosis was carcinoma. Even though the patient was still alive after 33 months, this limited resection may not be curative. Our group previously described a patient whose frozen sections of the pancreatic margins were negative after middle pancreatectomy, but who had an invasive carcinoma with 2 positive satellite lymph nodes. 32 Finally, limited resection is possible in highly selected patients who fulfill the following criteria: branch duct tumor less than 30 mm and absence of mural nodules at preoperative and intraoperative examinations. In only these specific patients, limited resection such as middle pancreatectomy for a tumor localized at the isthmus, or inferior head resection for a tumor localized in the uncinate process of the pancreas, can be adequate with a curative intent. Accepted for publication May 18, Corresponding author: Christian Partensky, MD, Department of Surgery, Hospital E. Herriot, Lyon CEDEX 03, France ( 1277
5 REFERENCES 1. Klöppel G, Solicia E, Longnecker D, et al. Histological Classification of Tumors of the Exocrine Pancreas. 2nd ed. New York, NY: Springer Verlag; Sugiyama M, Atomi Y. Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg. 1998;228: Paye F, Sauvanet A, Terris B, et al. Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery. 2000;127: Azar C, Van de Stadt J, Rickaert F, et al. Intraductal papillary mucinous tumours of the pancreas: clinical and therapeutic issues in 32 patients. Gut. 1996;39: Barbe L, Ponsot P, Vilgrain V, et al. Tumeurs intra-canalaires papillaires mucineuses pancréatiques. Gastroenterol Clin Biol. 1997;21: Cuillerier E, Cellier C, Palazzo L, et al. Tumeurs intracanalaires papillaires mucineuses du pancréas: existe-t-il des facteurs pré-opératoires cliniques et bilologiques prédictifs de dégénérescence? résultats d une série collective francobelge. Ann Chir. 1998;52: Kaneko T, Nakao A, Inoue S, et al. Intraoperative ultrasonography by highresolution annular array transducer for intraductal papillary mucinous tumors of the pancreas. Surgery. 2001;129: Traverso LW, Peralta EA, Ryan JA Jr, Kozarek RA. Intraductal neoplasms of the pancreas. Am J Surg. 1998;175: Cuillerier E, Cellier C, Palazzo L, et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol. 2000;95: Yamao K, Ohashi K, Nakamura T, et al. The prognosis of intraductal papillary mucinous tumors of the pancreas. Hepatogastroenterology. 2000;47: Kimura W, Makuuchi M, Kuroda A. Characteristics and treatment of mucinproducing tumor of the pancreas. Hepatogastroenterology. 1998;45: Partensky C, Berger F. Les tumeurs intracanalaires papillaires et mucineuses du pancréas. In: Le Borgne J, de Calan L, Partensky C. Les tumeurs kystiques du pancréas. Monographie de l Association Française de Chirurgie: Rapport présenté au 99 Congrès Français de Chirurgie. Paris, France: Arnette Blackwell; 1997: Willemart S, Nicaise N, Deviere J, et al. Tumeurs intracanalaires mucosécrétantes et papillaires du pancréas: considérations clinico-pathologiques et aspects radiologiques comprenant la sémiologie tomodensitométrique. J Belge Radiol. 1998;81: Sho M, Nakajima Y, Kanehiro H, et al. Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas. World J Surg. 1998;22: Sohn TA, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH, Lillemoe KD. Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg. 2001;234: Terris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol. 2000;24: Nakagohri T, Kenmochi T, Kainuma O, Tokoro Y, Asano T. Intraductal papillary mucinous tumors of the pancreas. Am J Surg. 1999;178: Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg. 1999;134: Sugiyama M, Atomi Y, Saito M. Intraductal papillary tumors of the pancreas: evaluation with endoscopic ultrasonography. Gastrointest Endosc. 1998;48: Adsay NV, Longnecker DS, Klimstra DS. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms. Semin Diagn Pathol. 2000;17: Tateishi K, Tada M, Yamagata M, et al. High proportion of mutant K-ras gene in pancreatic juice of patients with pancreatic cystic lesions. Gut. 1999;45: Inui K, Nakazawa S, Yoshino J, et al. Mucin-producing tumor of the pancreas intraluminal ultrasonography. Hepatogastroenterology. 1998;45: Siech M, Tripp K, Schmidt-Rohlfing B, Mattfeldt T, Gorich J, Beger HG. Intraductal papillary mucinous tumor of the pancreas. Am J Surg. 1999;177: Klöppel G. Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas. Hepatogastroenterology. 1998;45: Kaye PS, Steinberg SE, Montbriand JR. Intraductal papillary-mucinous tumor of the pancreas: presentation in a young adult. Am J Gastroenterol. 1999;94: Partensky C, Laugier R. Tumeurs intra-canalaires papillaires mucineuses pancréatiques: quelle chirurgie pour quelle tumeur? Gastroenterol Clin Biol. 2000; 24: Gigot J-F, Deprez P, Sempoux C, et al. Surgical management of intraductal papillary mucinous tumors of the pancreas: the role of routine frozen section of the surgical margin, intraoperative endoscopic staged biopsies of the Wirsung duct, and pancreaticogastric anastomosis. Arch Surg. 2001;136: de Stadt JV, Closset J, Gelin M. Intraductal papillary mucinous tumors (IPMT). Ann Surg. 1999;230: Yasuda H, Takada T, Amano H, Yoshida M. Surgery for mucin-producing pancreatic tumor. Hepatogastroenterology. 1998;45: Nakao A. Pancreatic head resection with segmental duodenectomy and preservation of the gastroduodenal artery. Hepatogastroenterology. 1998;45: Nakagohri T, Kenmochi T, Kainuma O, Tokoro Y, Kobayashi S, Asano T. Inferior head resection of the pancreas for intraductal papillary mucinous tumors. Am J Surg. 2000;179: Partensky C, Apa D, Marchal F, Meziat A, Berger F. Pancréatectomie médiane avec anastomose pancréatogastrique pour néoformation pancréatique. Chirurgie. 1998;123: Sciaudone G, Perniceni T, Levy P, Bougaran J, Gaye B. Enucléation de tumeur intracanalaire papillaire et mucineuse de la tête du pancréas. Gastroenterol Clin Biol. 2000;24: Takeyoshi I, Ohwada S, Nakamura S, et al. Segmental pancreatectomy for mucinproducing pancreatic tumors. Hepatogastroenterology. 1999;46:
ORIGINAL ARTICLE. Fate of the Pancreatic Remnant After Resection for an Intraductal Papillary Mucinous Neoplasm
ONLINE FIRST ORIGINAL ARTICLE Fate of the Pancreatic Remnant After Resection for an Intraductal Papillary Mucinous Neoplasm A Longitudinal Level II Cohort Study Toshiyuki Moriya, MD, PhD; L. William Traverso,
More informationA Multicentric Development Of Intraductal Papillary Mucinous Neoplasm Treated By Repeated Pancreatectomy
ISPUB.COM The Internet Journal of Surgery Volume 7 Number 2 A Multicentric Development Of Intraductal Papillary Mucinous Neoplasm Treated By Repeated T Matsumoto, K Iwaki, H Uchida, K Yada, K Shibata,
More informationCitation American Journal of Surgery, 196(5)
NAOSITE: Nagasaki University's Ac Title Author(s) Multifocal branch-duct pancreatic i neoplasms Tajima, Yoshitsugu; Kuroki, Tamotsu Amane; Adachi, Tomohiko; Mishima, T Kanematsu, Takashi Citation American
More informationPredictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas
Korean J Hepatobiliary Pancreat Surg 2011;15:27-22 Original Article Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas Dae Young Jun 1, Hyung Jun Kwon 2, Sang Geol
More informationIntraductal papillary mucinous neoplasm (IPMN) is a distinct
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6:815 819 Evaluation of the Guidelines for Management of Pancreatic Branch-Duct Intraductal Papillary Mucinous Neoplasm RAYMOND S. TANG,* BENJAMIN WEINBERG,
More informationIntraductal Papillary Mucinous Neoplasms: We Still Have a Way to Go! Francesco M. Serafini, MD, FACS
Intraductal Papillary Mucinous Neoplasms: We Still Have a Way to Go! Francesco M. Serafini, MD, FACS Brooklyn VAMC September 21 st GI Grand Rounds - What is it? - Clinical entity that has emerged from
More informationPAPER. Experience With 208 Resections for Intraductal Papillary Mucinous Neoplasm of the Pancreas
PAPER Experience With 0 Resections for Intraductal Papillary Mucinous Neoplasm of the Pancreas Thomas Schnelldorfer, MD; Michael G. Sarr, MD; David M. Nagorney, MD; Lizhi Zhang, MD; Thomas C. Smyrk, MD;
More informationAccording to the international consensus guidelines for
ORIGINAL ARTICLE Natural History of Branch Duct Intraductal Papillary Mucinous Neoplasm With Mural Nodules A Japan Pancreas Society Multicenter Study Go Kobayashi, MD, PhD,* Naotaka Fujita, MD, PhD,* Hiroyuki
More informationCitation Hepato-Gastroenterology, 55(86-87),
NAOSITE: Nagasaki University's Ac Title Author(s) Combined pancreatic resection and p multiple lesions of the pancreas: i of the pancreas concomitant with du Kuroki, Tamotsu; Tajima, Yoshitsugu Tomohiko;
More informationTotal pancreatectomy in six patients with intraductal papillary mucinous tumour of the pancreas: the treatment of choice
HPB 2001 Volume 3, Number 4 257 262 Total pancreatectomy in six patients with intraductal papillary mucinous tumour of the pancreas: the treatment of choice J Bendix Holme 1, NO Jacobsen 2, M Rokkjaer
More informationThe Use of Pancreatoscopy in the Diagnosis of Intraductal Papillary Mucinous Tumor Lesions of the Pancreas
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:S53 S57 The Use of Pancreatoscopy in the Diagnosis of Intraductal Papillary Mucinous Tumor Lesions of the Pancreas KENJIRO YASUDA, MUNEHIRO SAKATA, MOOSE
More informationA pancreatic intraductal papillary mucinous neoplasm: A case report and literature review
Case report A pancreatic intraductal papillary mucinous neoplasm: A case report and literature review Martín A. Gómez Z., MD, 1 Cristian Melgar, MD, 2 Germán Junca, MD. 3 1 Gastroenterology Professor,
More informationPancreatic Disorders & Therapy
ISSN: 2165-7092 rpancreatic Disorders & The apy Review Article Pancreatic Disorders & Therapy Kimura and Tezuka, 2015, 5:1 DOI: 10.4172/2165-7092.1000148 Open Access Acute Pancreatitis is a Predictive
More informationFDG-PET Findings of Intraductal Oncocytic Papillary Neoplasms of the Pancreas: Two Case Reports
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article
More informationMucin-Producing Neoplasms of the Pancreas: An Analysis of Distinguishing Clinical and Epidemiologic Characteristics
Mucin-Producing Neoplasms of the Pancreas: An Analysis of Distinguishing Clinical and Epidemiologic Characteristics The Harvard community has made this article openly available. Please share how this access
More informationBranch duct intraductal papillary mucinous neoplasm of the pancreas: single-center experience with 324 patients who underwent surgical resection
Korean J Hepatobiliary Pancreat Surg 2015;19:113-120 http://dx.doi.org/10.14701/kjhbps.2015.19.3.113 Original Article Branch duct intraductal papillary mucinous neoplasm of the pancreas: single-center
More informationChronic pancreatitis mimicking intraductal papillary mucinous neoplasm of the pancreas; Report of tow cases
Jichi Medical University Journal Chronic pancreatitis mimicking intraductal papillary mucinous neoplasm of the pancreas; Report of tow cases Noritoshi Mizuta, Hiroshi Noda, Nao Kakizawa, Nobuyuki Toyama,
More informationSun A Kim Eunsil Yu Song Cheol Kim 1 Jihun Kim
The Korean Journal of Pathology 2010; 44: 410-9 DOI: 10.4132/KoreanJPathol.2010.44.4.410 Clinical Outcome of Surgically Resected Pancreatic Intraductal Papillary Mucinous Neoplasm ccording to the Marginal
More informationORIGINAL ARTICLE. for Mucin-Producing Tumors of the Pancreas
ORIGINAL ARTICLE Intraoperative Pancreatoscopy With the Ultrathin Pancreatoscope for Mucin-Producing Tumors of the Pancreas Tetsuya Kaneko, MD; Akimasa Nakao, MD; Shuji Nomoto, MD; Tsuyoshi Furukawa, MD;
More informationpissn: , eissn: Yonsei Med J 53(1): , 2012
Original Article http://dx.doi.org/10.3349/ymj.2012.53.1.106 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 53(1):106-110, 2012 Comparison of Efficacy of Enucleation and Pancreaticoduodenectomy for Small
More informationPersPeCTIves. Controversies in the management of pancreatic ipmn. Masao Tanaka
PersPeCTIves OpiniOn Controversies in the management of pancreatic ipmn Masao Tanaka Abstract Although considerable progress has been made in our understanding of intraductal papillary mucinous neoplasm
More informationp53 expression in invasive pancreatic adenocarcinoma and precursor lesions
Malaysian J Pathol 2011; 33(2) : 89 94 ORIGINAL ARTICLE p53 expression in invasive pancreatic adenocarcinoma and precursor lesions NORFADZILAH MY MBBCH,* Jayalakshmi PAILOOR MPath, FRCPath,* RETNESWARI
More informationSurgical outcomes of multifocal branch duct intraductal papillary mucinous neoplasms of pancreas
Korean J Hepatobiliary Pancreat Surg 2014;18:152-158 http://dx.doi.org/10.14701/kjhbps.2014.18.4.152 Original Article Surgical outcomes of multifocal branch duct intraductal papillary mucinous neoplasms
More informationORIGINAL ARTICLE. Intraductal Papillary Mucinous Tumors of the Pancreas Comprise 2 Clinical Subtypes
ORIGINAL ARTICLE Intraductal Papillary Mucinous Tumors of the Pancreas Comprise 2 Clinical Subtypes Differences in Clinical Characteristics and Surgical Management Masao Kobari, MD; Shinn-ichi Egawa, MD;
More informationRecently, intraductal papillary-mucinous tumors
GASTROENTEROLOGY 2002;122:34 43 Diagnosis and Patient Management of Intraductal Papillary- Mucinous Tumor of the Pancreas by Using Peroral Pancreatoscopy and Intraductal Ultrasonography TARO HARA,* TAKETO
More informationInagaki M, Obara M, Kino S, Goto J, Suzuki S, Ishizaki A, Tanno S, Kohgo Y, Tokusashi Y, Miyokawa N, Kasai S.
Journal of Hepato-Biliary-Pancreatic Surgery (2007) 14(3):264-269. Pylorus-preserving total pancreatectomy for an intraductal papillarymucinous neoplasm of the pancreas. Inagaki M, Obara M, Kino S, Goto
More informationIntraductal Papillary Mucinous Neoplasm of the Pancreas. Masao Tanaka Editor
Intraductal Papillary Mucinous Neoplasm of the Pancreas Masao Tanaka Editor Intraductal Papillary Mucinous Neoplasm of the Pancreas Masao Tanaka Editor Intraductal Papillary Mucinous Neoplasm of the Pancreas
More informationDifferential Diagnosis of Benign and Malignant Intraductal Papillary Mucinous Tumors of the Pancreas: MR Cholangiopancreatography
Differential Diagnosis of Benign and Malignant Intraductal Papillary Mucinous Tumors of the Pancreas: MR Cholangiopancreatography and MR Angiography Byung Se Choi, MD 1 Tae Kyoung Kim, MD 1 Ah Young Kim,
More informationIntraductal papillary mucinous neoplasm of the bile ducts: a rare form of premalignant lesion of invasive cholangiocarcinoma
Intraductal papillary mucinous neoplasm of the bile ducts: a rare form of premalignant lesion of invasive cholangiocarcinoma Authors: R. Revert Espí, Y. Fernandez Nuñez, I. Carbonell, D. P. Gómez valencia,
More informationSurgical management and results for cystic neoplasms of pancreas
Korean J Hepatobiliary Pancreat Surg 2013;17:118-125 Original Article Surgical management and results for cystic neoplasms of pancreas Kyung Won Han 1, Ryun Ha 1, Kun Kuk Kim 1, Jung Nam Lee 1, Yeon Suk
More informationRole of Endoscopic Ultrasound in the Diagnosis of Intraductal Papillary Mucinous Neoplasms: Correlation With Surgical Histopathology
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2007;5:489 495 Role of Endoscopic Ultrasound in the Diagnosis of Intraductal Papillary Mucinous Neoplasms: Correlation With Surgical Histopathology SHIREEN A. PAIS,*
More informationYoshitsugu; Kanematsu, Takashi; Kur
NAOSITE: Nagasaki University's Ac Title Author(s) Citation Laparoscopic Middle Pancreatectomy Surgery Kitasato, Amane; Adachi, Tomohiko; Yoshitsugu; Kanematsu, Takashi; Kur Hepato-Gastroenterology, 59(120),
More informationIntraductal papillary neoplasms in the bile ducts
Intraductal papillary neoplasms in the bile ducts Seok Hwa Youn Myunghee Yoon Dong Hoon Shin Kosin University Gospel Hospital Department of general surgery Hepato-biliary-pancreatic division Introduction
More informationA large mural nodule in branch duct intraductal papillary mucinous adenoma of the pancreas: a case report
Haruki et al. Surgical Case Reports (2015) 1:20 DOI 10.1186/s40792-014-0009-x CASE REPORT Open Access A large mural nodule in branch duct intraductal papillary mucinous adenoma of the pancreas: a case
More informationACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts
ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts Grace H. Elta, MD, FACG 1, Brintha K. Enestvedt, MD, MBA 2, Bryan G. Sauer, MD, MSc, FACG (GRADE Methodologist) 3 and Anne Marie Lennon,
More informationSelect problems in cystic pancreatic lesions
Disclosure Select problems in cystic pancreatic lesions Five Prime Therapeutics shareholder Adicet Bio shareholder Bristol-Meyer Squibb advisory board grace.kim@ucsf.edu Pancreatic cystic lesions Intraductal
More information322 Cancer Control. Tumor Board Presentation. Interdisciplinary Management of an Intraductal Papillary Mucinous Neoplasm of the Pancreas
Tumor Board Presentation Cancer Control Journal of the Moffitt Cancer Center Interdisciplinary Management of an Intraductal Papillary Mucinous Neoplasm of the Pancreas Rajesh M. Nair, MD, James S. Barthel,
More informationObjectives. Intraoperative Consultation of the Whipple Resection Specimen. Pancreas Anatomy. Pancreatic ductal carcinoma 11/10/2014
Intraoperative Consultation of the Whipple Resection Specimen Pathology Update Faculty of Medicine, University of Toronto November 15, 2014 John W. Wong, MD, FRCPC Department of Anatomical Pathology Sunnybrook
More informationMagnetic resonance cholangiopancreatography (MRCP) is an imaging. technique that is able to non-invasively assess bile and pancreatic ducts,
SECRETIN AUGMENTED MRCP Riccardo MANFREDI, MD, MBA, FESGAR Magnetic resonance cholangiopancreatography (MRCP) is an imaging technique that is able to non-invasively assess bile and pancreatic ducts, in
More informationSYSTEMATIC REVIEWS AND META-ANALYSES
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2013;11:913 921 SYSTEMATIC REVIEWS AND META-ANALYSES Fasiha Kanwal, Section Editor Cyst Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasms
More informationValue of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms
22 Original article Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms Authors Ken Kamata 1, Masayuki Kitano 1, Masatoshi Kudo
More informationDisclosure of Relevant Financial Relationships
Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS
More informationA Selective Approach to Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients
LETTER TO THE EDITOR A Selective Approach to Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients To the Editor: I would like to congratulate Dr. Allen and colleagues for
More informationThe Pancreas. Basic Anatomy. Endocrine pancreas. Exocrine pancreas. Pancreas vasculature. Islets of Langerhans. Acinar cells Ductal System
SGNA: Back to Basics Rogelio G. Silva, MD Assistant Clinical Professor of Medicine University of Illinois at Chicago Department of Medicine Division of Gastroenterology Advocate Christ Medical Center GI
More informationPancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)
Pancreas Quizzes Quiz 1 1. The pancreas produces hormones. Which type of hormone producing organ is the pancreas? a. Endocrine b. Exocrine c. Both A and B d. Neither A or B 2. Endocrine indicates hormones
More informationEvaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts
Evaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts Authors Alexander Lee 1, Vivek Kadiyala 2,LindaS.Lee 3 Institutions 1 Texas Digestive Disease Consultants,
More informationMultiple Primary Quiz
Multiple Primary Quiz Case 1 A 72 year old man was found to have a 12 mm solid lesion in the pancreatic tail by computed tomography carried out during a routine follow up study of this patient with adult
More informationClinical Paper Virtual Pancreatoscopy of Mucin-Producing Pancreatic Tumors
Computer Aided Surgery 3:264 268 (1998) Clinical Paper Virtual Pancreatoscopy of Mucin-Producing Pancreatic Tumors Toshio Nakagohri, M.D., Ferenc A. Jolesz, M.D, Shigeo Okuda, M.D., Takehide Asano, M.D.,
More information5/17/2013. Pancreatic Cancer. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Case presentation. Differential diagnosis
Overview Case presentation Postgraduate Course in General Surgery Differential diagnosis Diagnosis and therapy Eric K. Nakakura Koloa, HI March 26, 2013 Outcomes CASE 1: CASE 1: A 78-year-old man developed
More informationCongenital dilatation of the common bile duct and pancreaticobiliary maljunction clinical implications
Langenbecks Arch Surg (2009) 394:209 213 DOI 10.1007/s00423-008-0330-6 CURRENT CONCEPT IN CLINICAL SURGERY Congenital dilatation of the common bile duct and pancreaticobiliary maljunction clinical implications
More informationIntraductal Papillary Mucinous Neoplasm (IPMN) and Chronic Pancreatitis: Overlapping Pathological Entities? Two Case Reports
CASE REPORT Intraductal Papillary Mucinous Neoplasm (IPMN) and Chronic Pancreatitis: Overlapping Pathological Entities? Two Case Reports Athanasios Petrou 1, Alexandros Papalambros 2, Nicholas Brennan
More informationHistopathologic Findings of Multifocal Pancreatic Intraductal Papillary Mucinous Neoplasms on CT
Gastrointestinal Imaging Original Research Raman et al. CT of Multifocal Pancreatic IPMNs Gastrointestinal Imaging Original Research Siva P. Raman 1 Satomi Kawamoto 1 Amanda Blackford 2 Ralph H. Hruban
More informationCystic Lesions of the Pancreas: Changes in the Presentation and Management of 1,424 Patients at a Single Institution over a 15-Year Time Period
Cystic Lesions of the Pancreas: Changes in the Presentation and Management of 1,424 Patients at a Single Institution over a 15-Year Time Period Sébastien Gaujoux, MD, PhD, Murray F Brennan, MD, FACS, Mithat
More informationIntraductal Papillary Mucinous Neoplasms: The Bologna Experience
ORIGINAL ARTICLE INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM Intraductal Papillary Mucinous Neoplasms: The Bologna Experience Riccardo Casadei 1, Carlo Alberto Pacilio 1, Claudio Ricci 1, Giovanni Taffurelli
More informationOutline. Intraductal Papillary Mucinous Neoplasm (IPMN) Guideline Review 4/6/2017. Case Example Background Classification Histology Guidelines
Intraductal Papillary Mucinous Neoplasm (IPMN) Guideline Review The Nurse Practitioner Association New York State Capital Region Teaching Day Matthew Warndorf MD Case Example Background Classification
More information3/28/2012. Periampullary Tumors. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Eric K. Nakakura Ko Olina, HI
Overview Postgraduate Course in General Surgery Case presentation Differential diagnosis Diagnosis and therapy Outcomes Principles of palliative care Eric K. Nakakura Ko Olina, HI March 27, 2012 CASE 1:
More informationManagement of the Mucin Filled Bile Duct. A Complication of Intraductal Papillary Mucinous Tumor of the Pancreas
CASE REPORT Management of the Mucin Filled Bile Duct. A Complication of Intraductal Papillary Mucinous Tumor of the Pancreas Anand Patel, Louis Lambiase, Antonio Decarli, Ali Fazel Division of Gastroenterology
More informationVirtual MR Pancreatoscopy in the Evaluation of the Pancreatic Duct in Chronic Pancreatitis
MULTIMEDIA ARTICLE - Videoclips Virtual MR Pancreatoscopy in the Evaluation of the Pancreatic Duct in Chronic Pancreatitis Rakesh Kalapala 1, Lingareddy Sunitha 2, Reddy D Nageshwar 1, Guduru V Rao 1,
More informationMiddle segment-preserving pancreatectomy for metachronous intraductal papillary mucinous neoplasm after pancreatoduodenectomy: a case report
Yamada et al. Surgical Case Reports (2017) 3:28 DOI 10.1186/s40792-017-0306-2 CASE REPORT Middle segment-preserving pancreatectomy for metachronous intraductal papillary mucinous neoplasm after pancreatoduodenectomy:
More informationREVIEW ARTICLE INTRODUCTION SURGICAL MANAGEMENT ABSTRACT
JOP. J Pancreas (Online) 2015 Sep 08; 16(5):417-424. REVIEW ARTICLE Fate of the Pancreatic Remnant Following Curative Intent Surgical Resection for Intraductal Pancreatic Mucinous Neoplasms: An Overview
More informationMatthew McCollough, M.D. April 9, 2009 University of Louisville
Matthew McCollough, M.D. April 9, 2009 University of Louisville List the differential diagnosis for pancreatic cysts Review the epidemiology Illustrate the types of cysts through case discussions Discuss
More informationIntraductal Papillary-Mucinous Neoplasm of the Pancreas Penetrating to the Stomach and the Common Bile Duct
CASE REPORT Intraductal Papillary-Mucinous Neoplasm of the Pancreas Penetrating to the Stomach and the Common Bile Duct Norihiro Goto 1, Masahiro Yoshioka 1, Motohito Hayashi 1, Toshinao Itani 1, Jun Mimura
More informationE ndoscopic retrograde cholangiopancreatography (ERCP)
240 BILIARY DISEASE Endoscopic transpapillary biopsies and intraductal ultrasonography in the diagnostics of bile duct strictures: a prospective study D Domagk, C Poremba, K-H Dietl, N Senninger, A Heinecke,
More informationNeoplasias Quisticas del Páncreas
SEAP -Aproximación Práctica a la Patología Gastrointestinal- Madrid, 26 de mayo, 2006 Neoplasias Quisticas del Páncreas Gregory Y. Lauwers, M.D. Director, Service Massachusetts General Hospital Harvard
More information1 Department of Gastroenterology and Pancreatology, Beaujon Hospital, France 3 Department or Radiology, Beaujon Hospital, University Paris 7, Clichy,
Original Article Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas United European Gastroenterology
More informationThe role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms
The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms CYSTIC LESIONS AND FLUID COLLECTIONS OF THE PANCREAS Their pathology ranges from pseudocysts and pancreatic necrosis
More informationContemporary Results with Ampullectomy for 29 Benign Neoplasms of the Ampulla
Contemporary Results with Ampullectomy for 29 Benign Neoplasms of the Ampulla Stephen R Grobmyer, MD, Chad N Stasik, MD, Peter Draganov, MD, Alan W Hemming, MD, FACS, Lisa R Dixon, MD, Stephen B Vogel,
More informationC ystic neoplasms of the pancreas are uncommon
712 PANCREAS Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma
More informationAppendix 4: WHO Classification of Tumours of the pancreas 17
S3.01 The WHO histological tumour type must be recorded. CS3.01a The histological type of the tumour should be recorded based on the current WHO classification 17 (refer to Appendices 4-7). Appendix 4:
More informationOncologist. The. Gastrointestinal Cancer. Intraductal Papillary Mucinous Tumors of the Pancreas: Biology, Diagnosis, and Treatment
The Oncologist Gastrointestinal Cancer Intraductal Papillary Mucinous Tumors of the Pancreas: Biology, Diagnosis, and Treatment ROBERT GRÜTZMANN, a MARCO NIEDERGETHMANN, b CHRISTIAN PILARSKY, a GÜNTER
More informationAn Intraductal Papillary Neoplasm of the Bile Duct at the Duodenal Papilla
Published online: July 2, 2014 1662 6575/14/0072 0417$39.50/0 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial 3.0 Unported license (CC BY-NC)
More informationIntraductal Papillary Mucinous Neoplasm of Pancreas
Review Article Intraductal Papillary Mucinous Neoplasm of Pancreas Norman Oneil Machado, Hani al Qadhi, Khalifa al Wahibi Department of Surgery, Sultan Qaboos University Hospital, Muscat, Oman Abstract
More informationAn Approach to Pancreatic Cysts. Introduction
An Approach to Pancreatic Cysts Nalini M. Guda, MD Aurora St. Luke s Medical Center, Milwaukee Clinical Adjunct Professor of Medicine, University of Wisconsin School of Medicine and Public Health Introduction
More informationCalcifying Obstructive Pancreatitis: A Study of Intraductal Papillary Mucinous Neoplasm Associated With Pancreatic Calcification
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2004;2:57 63 Calcifying Obstructive Pancreatitis: A Study of Intraductal Papillary Mucinous Neoplasm Associated With Pancreatic Calcification MAURICIO ZAPIACH,*
More informationJefferson Digital Commons. Thomas Jefferson University. Charles Galanis The Johns Hopkins Medical Institutions
Thomas Jefferson University Jefferson Digital Commons Department of Surgery Faculty Papers Department of Surgery July 2007 Resected serous cystic neoplasms of the pancreas: Locally aggressive behavior
More informationTypes of IPMN. Pancreas Cysts: An Incidental Finding or Harbinger of Malignancy. Cysts: Early Neoplasia. Mucinous Cystic Lesions. EUS-guided FNA EUS
Pancreas Cysts: An Incidental Finding or Harbinger of Malignancy EUS-guided FNA William R. Brugge,, MD, FACG Professor of Medicine Harvard Medical School Director, GI Endoscopy Unit Massachusetts General
More informationDiagnosis of tumor extension in biliary carcinoma has. Differential Diagnosis and Treatment of Biliary Strictures
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2009;7:S79 S83 Differential Diagnosis and Treatment of Biliary Strictures KAZUO INUI, JUNJI YOSHINO, and HIRONAO MIYOSHI Department of Internal Medicine, Second
More informationReport of a case of pancreatic hemangioma: A difficult preoperative diagnosis
www.edoriumjournals.com CASE REPORT PEER REVIEWED OPEN ACCESS Report of a case of pancreatic hemangioma: A difficult preoperative diagnosis AL Hashmi Al Warith, Lagrange Xavier, Fara Régis, Camerlo Antoine
More informationCase Report A Case Report of Intraductal Papillary-Mucinous Neoplasm of the Pancreas Showing Morphologic Transformation during Followup Periods
Oncology Volume 2009, Article ID 373465, 6 pages doi:10.1155/2009/373465 Case Report A Case Report of Intraductal Papillary-Mucinous Neoplasm of the Pancreas Showing Morphologic Transformation during Followup
More informationORIGINAL ARTICLE. Helical Computed Tomography in the Diagnosis of Portal Vein Invasion by Pancreatic Head Carcinoma
ORIGINAL ARTICLE Helical Computed Tomography in the Diagnosis of Portal Vein Invasion by Pancreatic Head Carcinoma Usefulness for Selecting Surgical Procedures and Predicting the Outcome Hiroyoshi Furukawa,
More informationPancreatic Cysts. Darius C. Desai, MD FACS St. Luke s University Health Network
Pancreatic Cysts Darius C. Desai, MD FACS St. Luke s University Health Network None Disclosures Incidence Widespread use of cross sectional imaging Seen in over 2% of patients having abdominal imaging
More informationAnatomical and Functional MRI of the Pancreas
Anatomical and Functional MRI of the Pancreas MA Bali, MD, T Metens, PhD Erasme Hospital Free University of Brussels Belgium mbali@ulb.ac.be Introduction The use of MRI to investigate the pancreas has
More informationPancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas.
Pancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition Procedures Cytology (No Accompanying Checklist)
More informationOncologist. The. Hepatobiliary. Management of Mucin-Producing Cystic Neoplasms of the Pancreas. The Oncologist 2009;14:
The Oncologist Hepatobiliary Management of Mucin-Producing Cystic Neoplasms of the Pancreas STEFAN FRITZ, ANDREW L. WARSHAW, SARAH P. THAYER Department of Surgery, Massachusetts General Hospital, Boston,
More informationLarge Colorectal Adenomas An Approach to Pathologic Evaluation
Anatomic Pathology / LARGE COLORECTAL ADENOMAS AND PATHOLOGIC EVALUATION Large Colorectal Adenomas An Approach to Pathologic Evaluation Elizabeth D. Euscher, MD, 1 Theodore H. Niemann, MD, 1 Joel G. Lucas,
More informationEndoscopic Ultrasonography Clinical Impact. Giancarlo Caletti. Gastroenterologia Università di Bologna. Caletti
Clinical Impact Giancarlo Gastroenterologia Università di Bologna AUSL di Imola,, Castel S. Pietro Terme (BO) 1982 Indications Diagnosis of Submucosal Tumors (SMT) Staging of Neoplasms Evaluation of Pancreato-Biliary
More informationThe Role of Molecular Analysis in the Diagnosis and Surveillance of Pancreatic Cystic Neoplasms
JOP. J Pancreas (Online) 20 Mar 20; (2):-9. RESEARCH ARTICLE The Role of Molecular Analysis in the Diagnosis and Surveillance of Pancreatic Cystic Neoplasms Megan Winner, Amrita Sethi 2, John M Poneros
More informationPancreatobiliary Frozen Section Nightmares
Pancreatobiliary Frozen Section Nightmares Aatur D. Singhi, MD PhD Assistant Professor University of Pittsburgh Medical Center Department of Pathology singhiad@upmc.edu Objectives Briefly give an overview
More informationJournal of Interventional Gastroenterology A Combination of Snare Polypectomy and APC Therapy for Prolapsing Common Bile Duct Adenoma
Journal of Interventional Gastroenterology A Combination of Snare Polypectomy and APC Therapy for Prolapsing Common Bile Duct Adenoma --Manuscript Draft-- Manuscript Number: Full Title: Article Type: Section/Category:
More informationOriginal article. Introduction!
382 Original article Peritoneal seeding in intraductal papillary mucinous neoplasm of the pancreas patients who underwent endoscopic ultrasound-guided fine-needle aspiration: The PIPE Study Authors Won
More informationCharacterization of Malignant Pancreatic Cystic Lesions in the Background of Chronic Pancreatitis
ORIGINAL ARTICLE Characterization of Malignant Pancreatic Cystic Lesions in the Background of Chronic Pancreatitis Dhanwant Gomez 1, Sakhawat H Rahman 1, Li Fong Wong 1, Caroline S Verbeke 2, Michael J
More informationEndoscopic Ultrasonography Assessment for Ampullary and Bile Duct Malignancy
Diagnostic and Therapeutic Endoscopy, Vol. 3, pp. 35-40 Reprints available directly from the publisher Photocopying permitted by license only (C) 1996 OPA (Overseas Publishers Association) Amsterdam B.V.
More informationTopics: Staging and treatment for pancreatic cancer. Staging systems for pancreatic cancer: Differences between the Japanese and UICC systems
M. J Hep Kobari Bil Pancr and S. Surg Matsuno: (1998) Staging 5:121 127 system for pancreatic cancer 121 Topics: Staging and treatment for pancreatic cancer Staging systems for pancreatic cancer: Differences
More informationSurgical treatment of incidentally identified pancreatic masses
Original Article Article original Surgical treatment of incidentally identified pancreatic masses Timothy L. Fitzgerald, MD; * Andrew J. Smith, MD, MSc; * Max Ryan, MD; Mostafa Atri, MD; Frances C. Wright,
More informationCase report. Open Access. Abstract
Open Access Case report Laparoscopic resection of a pancreatic serous cystadenoma preserving the integrity of main pancreatic duct: a case report Michail Pitiakoudis 1, Petros Zezos 2 *, Anastasia Oikonomou
More informationCase Scenario 1. Discharge Summary
Case Scenario 1 Discharge Summary A 69-year-old woman was on vacation and noted that she was becoming jaundiced. Two months prior to leaving on that trip, she had had a workup that included an abdominal
More informationTrans-abdominal ultrasound features of the newly named intraductal papillary neoplasm of the bile duct
Original Article on Translational Imaging in Cancer Patient Care Trans-abdominal ultrasound features of the newly named intraductal papillary neoplasm of the bile duct Xian-Shui Fu 1 *, Meng-Na He 2 *,
More informationCT 101 :Pancreas and Spleen
CT 101 :Pancreas and Spleen Shikha Khullar,, MD, MPH Division of Radiology University of South Alabama The Pancreas Normal Pancreas 3 Phase Pancreatic CT Non contrast Arterial phase : 30-35 35 second
More informationDr Claire Smith, Consultant Radiologist St James University Hospital Leeds
Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds Imaging in jaundice and 2ww pathway Image protocol Staging Limitations Pancreatic cancer 1.2.4 Refer people using a suspected
More informationNonsurgical Management of Asymptomatic Incidental Pancreatic Cysts
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2007;5:813 817 Nonsurgical Management of Asymptomatic Incidental Pancreatic Cysts MAOR LAHAV, YAKOV MAOR, BENJAMIN AVIDAN, BEN NOVIS, and SIMON BAR MEIR Department
More information